Durolane 60 MG/3 ML syringe 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9NH7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,775
Award facts
- Contract value 100% obligated
- $11,775.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,775.40 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on January 28, 2026, with an ultimate completion date of January 29, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a comprehensive IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The place of performance is Conshohocken, Pennsylvania.
Durolane is a hyaluronic acid-based intra-articular injection commonly used for osteoarthritis pain management, particularly in knee joints. This delivery order demonstrates AmerisourceBergen's role as a critical vendor in the federal medical procurement supply chain, fulfilling specialized pharmaceutical and medical device needs for military treatment facilities and defense healthcare systems. The company's extensive federal contract portfolio reflects its established capability to meet competitive procurement requirements across multiple therapeutic domains and medical commodity categories on behalf of the Department of Defense and related healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9NH7?
SPE2DR26F9NH7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F9NH7 worth?
The government has obligated $11,775 on SPE2DR26F9NH7.
Is contract SPE2DR26F9NH7 an order under another contract?
Yes. SPE2DR26F9NH7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NH7 competed?
The extent of competition for SPE2DR26F9NH7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award